Target intelligence / Profile preview

Respiratory Syncytial Virus Nucleoprotein N (RSV N)

Target
RSV N
Molecular classification
Structural protein, Viral protein, RNA-binding protein
01

Overview

The nucleoprotein N of respiratory syncytial virus (RSV) is a highly conserved structural protein essential for the virus’s life cycle. It encapsidates the viral negative-sense RNA genome, forming a ribonucleoprotein (RNP) complex that serves as the template for both mRNA synthesis and genome replication. The RNP complex is critical for protecting viral RNA from nucleases and ensuring efficient transcription and replication. The RSV N protein consists of 391 amino acids. It has two core domains: N-terminal domain (NTD) and C-terminal domain (CTD). These domains form a groove where the viral RNA binds. The structure also includes flexible extensions: N-arm (residues 1–28) and C-arm (residues 360–375). These arms interact with adjacent subunits in the helical nucleocapsid, stabilizing its structure while allowing flexibility. When bound to RNA, multiple N proteins oligomerize to form a left-handed helical nucleocapsid within the virion particle. Requires interaction with phosphoprotein P to remain in an RNA-free monomeric state before encapsidation; P acts as a chaperone preventing premature self-association or binding to cellular RNAs. Plays roles beyond structural support: Modulates host immune responses by sequestering host factors such as NF-kappa-B, IFIH1/MDA5, and MAVS into inclusion bodies within infected cells, thereby inhibiting innate immune signaling pathways. The RSV N protein is considered an attractive antiviral target due to its essential role in multiple stages of infection. Inhibitors like RSV604 have been shown to bind directly to this protein, disrupting its function and impeding virus replication.

Other names
Protein NNucleocapsid proteinNC protein
02

Mechanism of action

Inhibition of nucleoprotein function, disruption of virus replication

03

Biological functions

Genome encapsidationRNA protectionReplication templateTranscription templateImmune evasion
04

Disease associations

InfectionRespiratory disease
05

Interacting drugs

RSV604

Beyond the preview

Go deeper on Respiratory Syncytial Virus Nucleoprotein N (RSV N).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory Syncytial Virus Nucleoprotein N (RSV N).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call